Reduced PTLD-related mortality in patients experiencing EBV infection following allo-SCT after the introduction of a protocol incorporating pre-emptive rituximab-Reference-Cited by-同舟云学术

Reduced PTLD-related mortality in patients experiencing EBV infection following allo-SCT after the introduction of a protocol incorporating pre-emptive rituximab

Published:2013-06-10 Issue:11 Volume:48 Page:1465-1471
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

van der Velden W J F M,Mori T,Stevens W B C,de Haan A F J,Stelma F F,Blijlevens N M A,Donnelly J P

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt201384.pdf

Reference29 articles.

1. Styczynski J, Einsele H, Gil L, Ljungman P . Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases. Transpl Infect Dis 2009; 11: 383–392.

2. Loren AW, Porter DL, Stadtmauer EA, Tsai DE . Post-transplant lymphoproliferative disorder: a review. Bone Marrow Transplant 2003; 31: 145–155.

3. Heslop HE . How I treat EBV lymphoproliferation. Blood 2009; 114: 4002–4008.

4. Landgren O, Gilbert ES, Rizzo JD, Socie G, Banks PM, Sobocinski KA et al. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood 2009; 113: 4992–5001.

5. Hoegh-Petersen M, Goodyear D, Geddes MN, Liu S, Ugarte-Torres A, Liu Y et al. High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts. Bone Marrow Transplant 2011; 46: 1104–1112.

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of prophylaxis with rituximab on EBV-related complications after allogeneic hematopoietic cell transplantation in children;Frontiers in Immunology;2024-07-11

2. Effect of pre‐emptive rituximab on EBV DNA levels and prevention of post‐transplant lymphoproliferative disorder in pediatric kidney transplant recipients: A case series from the pediatric nephrology research consortium;Pediatric Transplantation;2024-04-02

3. Prospective Study of a Modified Post-Transplantation Cyclophosphamide Regimen for Severe Aplastic Anemia Patients with HLA-Haploidentical Transplantation;Transplantation and Cellular Therapy;2023-07

4. Who is the patient at risk for EBV reactivation and disease: expert opinion focused on post-transplant lymphoproliferative disorders following hematopoietic stem cell transplantation;Expert Opinion on Biological Therapy;2023-03-28

5. Cytomegalovirus and Epstein-Barr virus infection during daratumumab treatment in patients with multiple myeloma;Leukemia & Lymphoma;2023-02-03